#aging research

Life Biosciences, a startup co-founded by Harvard biologist David Sinclair, has announced an $80 million financing round to support a clinical test of a one-time anti-aging gene therapy.

A growing body of research suggests that the shingles vaccine does more than prevent a painful rash — it may significantly reduce the risk of dementia, including Alzheimer's disease, and even slow biological aging. The latest studies add to evidence that has been accumulating for years.